Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Dream Vacations (NYSE: CUK) Launches 14th Annual Franchise Giveaway for U.S. Military Veterans

Dream Vacations, a travel agency franchise brand under Carnival Corporation (NYSE: CUK), has launched its14th annual “Operation Vetrepreneur: Become Your Own General” contest, which offers military veterans a chance to win a free travel agency franchise. The 2025 contest will award three winners, each …

Team Kalkine | 07 July 2025

Valaris (NYSE: VAL) Adds USD 760Mn to Backlog with Multi-Year Contracts for DS-16 and DS-18

Valaris Limited (NYSE: VAL) has announced two contract awards involving its ultra-deepwater drillships, resulting in a combined addition of approximately USD760 million to its contracted revenue backlog.

Team Kalkine | 07 July 2025

Niu Technologies (NASDAQ: NIU) Reports 36.6% Year-Over-Year Growth in Q2 2025 Sales Volume

Niu Technologies (NASDAQ: NIU) has released its second quarter 2025 sales volume update, reporting total global unit sales of350,090, which reflects a36.6 percent increasecompared to256,162 unitssold in the same period last year.

Team Kalkine | 07 July 2025

Analyst Ratings Signal Mixed Outlook for Atlassian Shares (NASDAQ: TEAM)

Atlassian Corporation PLC (NASDAQ:TEAM), the maker of popular collaboration tools like Jira and Confluence, continues to attract mixed views from analysts as its stock trades significantly below prior highs.

Team Kalkine | 06 July 2025

Mixed Analyst Views Shape Outlook for Genpact Shares (NYSE:G)

Genpact Limited (NYSE:G), a global provider of business process outsourcing and IT services, has drawn a blend of ratings from Wall Street analysts in recent weeks, reflecting both confidence in its earnings track record and caution around valuation and market conditions.

Team Kalkine | 06 July 2025

Bristol-Myers Squibb (NYSE: BMY) Reaffirms Margin and Tax Targets, Raises FY25 Guidance

Bristol-Myers Squibb Company (NYSE: BMY)is a global biopharma leader dedicated to developing innovative treatments for serious diseases. Its pipeline spans therapeutic areas such as immunology, oncology, haematology, cardiovascular health, neuroscience, and more.

Team Kalkine | 04 July 2025

Palantir Technologies’ (NASDAQ: PLTR) Q1 Net Income Rises Above 100%, Reaffirms Positive FY25 Outlook

Palantir Technologies Inc. (NASDAQ: PLTR)develops software platforms like Gotham, Foundry, Apollo, and AIP which supports counterterrorism, data integration, secure system operations, and enterprise AI deployment using large language models.

Team Kalkine | 04 July 2025

Amazon (Nasdaq: AMZN) Lags Tech Peers in 2025 Despite USD100 Billion AI Investment

Amazon.com Inc. (Nasdaq: AMZN) is underperforming the broader technology sector in 2025, with its stock rising just under 2% year-to-date. This trails the S&P 500’s 7% and the Nasdaq-100’s 9% gains, amid intensifying competition in artificial intelligence and cloud infrastructure. Microsoft Corp. (Nasdaq: MSFT), …

Team Kalkine | 04 July 2025

Monte Rosa (Nasdaq: GLUE) Publishes AI-Driven Molecular Glue Research Expanding Over 100 Target Classes

Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE) announced the publication of new discoveries featured on the cover ofScience. The article,“Mining the CRBN Target Space Redefines Rules for Molecular Glue-induced Neosubstrate Recognition,”presents how Monte Rosa’s AI and machine learning engine uncovered a broad range of human …

Team Kalkine | 04 July 2025

MingZhu Logistics (Nasdaq: YGMZ) Signs Share Purchase Agreement to Acquire Mingzhuchun for Up to 6 Million Shares

MingZhu Logistics Holdings Limited (Nasdaq: YGMZ) has entered into a Share Purchase Agreement (SPA) to acquire full ownership of Shenzhen Mingzhuchun Wine Co., Ltd. The agreement includes the issuance of 2 million ordinary shares upon closing. Additionally, Mingzhuchun’s shareholder may receive two earnout payments …

Team Kalkine | 04 July 2025
Support

Hi! How can we help you today?

Loading…